엠파시타엠서방정25/100/1000밀리그램(엠파글리플로진,시타글립틴,메트포르민염산염)

대원

대원제약(주)

Marketing Authorization Holder · Finished Dosage FormsRepublic of Korea

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Tablets / Immediate-Release Tablets

Trade Type

Sell

Product Name

엠파시타엠서방정25/100/1000밀리그램(엠파글리플로진,시타글립틴,메트포르민염산염)

Details

Empagliflozin • Metformin Hydrochloride with Colloidal Anhydrous Silica • Sitagliptin Phosphate Hydrate

Substance

Empagliflozin • Metformin Hydrochloride with Colloidal Anhydrous Silica • Sitagliptin Phosphate Monohydrate

Registered Market

Republic of Korea

Specifications

Dosage Form: Extended-release tablet

Documents

Drug Marketing Authorization Number

Document No.: 5296

Issue Date: Jun 20, 2025

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product